GluBio (格博生物)
GluBio (格博生物) is a biotech company in San Diego, United States, founded in 2021. It has raised $102.0M across 3 rounds, most recently a $30.0M Corporate Round in February 2026.
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Total Funding
- $102.0M
- Last Round
- $30.0M Corporate RoundFeb 2026
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.
About
GluBio Therapeutics Inc. ("GluBio") is a biotechnology company dedicated to the discovery and development of novel molecular glue degraders (MGDs), with a mission to address unmet clinical needs across oncology, autoimmune diseases, and genetic disorders, etc. Since its establishment in March 2021, the company has secured funding from top-tier investors, including Hillhouse Capital, Qiming Venture Partners, Lilly Asia Ventures, Kaitai Capital, Legend Capital, K2VC, E Fund Capital and Sanofi.
Summary
It lists 11–50 employees. It has raised $102.0M in total across 3 rounds, most recently a $30.0M Corporate Round in Feb 2026. Investors include Sanofi Ventures, Qiming VP and Lilly Asia Ventures.
Funding History
Feb 2026
Sign up to see all 3 events
Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/glubio"><img src="https://indexed.vc/api/badge/company/glubio" alt="GluBio (格博生物) on Indexed.vc" width="260" height="76" /></a>